Hot
Human DR3 / TNFRSF25 Protein, His Tag, low endotoxin (Mass Spec & MALS verified)Cat. No. TN5-H52H3
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| DR3 | HOT TN5-H52H3 | Human DR3 / TNFRSF25 Protein, His Tag, low endotoxin (Mass Spec & MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $375.00 100ug | |
| DR3 | HOT DR3-H5253 | Human DR3 Protein, Fc Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $355.00 100ug | |
| DR3 | HOTAvitag DR3-H82E3 | Biotinylated Human DR3 / TNFRSF25 Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $400.00 25ug | |
| DR3 | Cynomolgus DR3 / TNFRSF25 Protein, His Tag, low endotoxin (SPR verified) | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $355.00 100ug | ||
| DR3 | Avitag DR3-H82F3 | Biotinylated Human DR3 / TNFRSF25 Protein, Fc,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $415.00 25ug | |
| DR3 | Mouse DR3 / TNFRSF25 Protein, His Tag, low endotoxin (HPLC & SPR verified) | Mouse | HEK293 | ![]() | HPLCSDS-PAGE | $355.00 100ug | ||
| DR3 | Cynomolgus DR3 / TNFRSF25 Protein, Fc Tag, low endotoxin | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $355.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Ontamalimab | SHP-647; PF-00547659; PF-547659 | Phase 3 Clinical | Pfizer Inc | Ileitis; Colitis, Ulcerative; Crohn Disease | Details |
| Vedolizumab biosimilar (Polpharma Biologics) | PB-016 | Phase 3 Clinical | Polpharma Biologics Sa | Pouchitis; Colitis, Ulcerative; Crohn Disease | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Vedolizumab | MLN-0002; LPD-02; MLN-002; MLN-02; LDP-02 | Approved | Millennium Pharmaceuticals Inc | 安吉优, Entyvio | United States | Colitis, Ulcerative; Crohn Disease | Takeda Pharmaceuticals USA Inc | 2014-05-20 | Celiac Disease; Carcinoma, Non-Small-Cell Lung; Melanoma; Crohn Disease; Gastritis; Urogenital Neoplasms; Colitis, Ulcerative; Cholangitis, Sclerosing; Pediatric ulcerative colitis; Solid tumours; Colitis; Pouchitis; Neoplasms; Pediatric Crohn's disease; Inflammatory Bowel Diseases; HIV Infections; Hematopoietic stem cell transplantation (HSCT) | Details |